Mouse Serine/threonine-Protein Kinase Receptor R3 (ACVL1) Protein

169€ (10 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Mouse Serine/threonine-Protein Kinase Receptor R3 (ACVL1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx691227
tested applications
SDS-PAGE
Description
Mouse Activin Receptor-like Kinase 1 Protein is a recombinant protein from Mouse produced in Human Cells. Recombinant Mouse Activin Receptor-like Kinase 1 is produced by our Mammalian expression system and the target gene encoding Asp23-Pro119 is expressed with a Fc tag at the C-terminus.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Activin Receptor-like Kinase 1 |
Host | Human |
Origin | Mouse |
Observed MW | Molecular Weight: 38.1 kDa Sequence Fragment: Asp23-Pro119 Tag: C-terminal Fc tag |
Expression | Recombinant |
Purity | > 95% (SDS-PAGE) |
Size 1 | 10 µg |
Size 2 | 50 µg |
Form | Lyophilized |
Tested Applications | SDS-PAGE |
Buffer | PBS, pH 7.4. |
Availability | Shipped within 5-15 working days. |
Storage | Store at < -20°C. |
Dry Ice | No |
UniProt ID | Q61288 |
Alias | Activin receptor-like kinase 1,ALK-1,SKR3 |
Background | Protein ACVRL1 |
Status | RUO |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
ACVRL1, also known as ALK1, is a type I receptor that primarily binds BMP9 and BMP10. It is critical for vascular development and endothelial cell function. ACVRL1 regulates angiogenesis through the SMAD1/5/8 signaling pathway, promoting endothelial proliferation and vessel stability. Mutations in ACVRL1 cause hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by abnormal blood vessel formation and recurrent bleeding. It is primarily expressed in vascular endothelial cells.
Related Products

ACVRL1 antibody
Type I receptor for TGF-beta family ligands BMP9/GDF2 and BMP10 and important regulator of normal blood vessel development. On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. May bind activin as well.
Ver Producto
Recombinant Human ALK-1
Ver Producto